Anupam Rasayan India Ltd. Publishes Post-Offer Advertisement for Bliss GVS Pharma Acquisition
Anupam Rasayan India Limited has published post-offer advertisements for its open offer to acquire 26.00% of Bliss GVS Pharma Limited. The acquisition is being undertaken with Mates Visa Consultancy Private Limited. Advertisements were published on September 1, 2026, in "Financial Express", "Jansatta", and "Nav Shakti".
This is a procedural announcement related to an existing open offer. It does not introduce new material information that would significantly impact the company's stock or operations.
The announcement is a routine regulatory filing regarding a public advertisement for an ongoing open offer. It does not contain new financial information or significant business updates that would impact the sentiment.
Anupam Rasayan India Limited (ARIL) has submitted newspaper advertisements regarding the post-offer advertisement for the open offer of Bliss GVS Pharma Limited. The open offer is for the acquisition of fully paid-up equity shares of face value ₹1 each, representing 26.00% of the expanded voting share capital of Bliss GVS Pharma Limited. The acquisition is being made by Anupam Rasayan India Limited, along with Mates Visa Consultancy Private Limited, acting as persons acting in concert (PAC).
This submission complies with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The advertisements were published on September 1, 2026, in "Financial Express" (English – All editions), "Jansatta" (Hindi – All editions), and "Nav Shakti" (Marathi - Mumbai edition). A copy of these advertisements will also be available on the company's website, www.anupamrasayan.com.
A plain-language summary of a public exchange filing by Anupam Rasayan India Limited. Read the original for the full detail.